<DOC>
	<DOCNO>NCT00487942</DOCNO>
	<brief_summary>The primary objective study evaluate adjunctive armodafinil treatment improve cognitive deficit patient schizophrenia</brief_summary>
	<brief_title>Efficacy Safety Armodafinil Adjunctive Therapy Schizophrenic Adults With Cognitive Deficits</brief_title>
	<detailed_description />
	<mesh_term>Schizophrenia</mesh_term>
	<mesh_term>Cognition Disorders</mesh_term>
	<mesh_term>Armodafinil</mesh_term>
	<mesh_term>Modafinil</mesh_term>
	<criteria>Key The patient diagnosis schizophrenia accord DSMIVTR criterion determine SCID clinically stable nonacute phase illness least 8 week prior baseline visit . The patient receive treatment olanzapine , oral risperidone , paliperidone schizophrenia least 6 week prior screen visit stable dose olanzapine , oral risperidone , paliperidone least 4 week prior screen visit . The patient prepare remain stable dosage duration study . The patient man woman 18 60 year age . The patient good health ( except diagnosis schizophrenia ) judge investigator basis medical psychiatric history , medical examination , ECG , serum chemistry , hematology , urinalysis . Women childbearing potential must use medically accept method contraception must agree continue use method duration study 30 day participation study . The patient must willing able comply study restriction , remain clinic require duration study period , return clinic followup evaluation specify protocol . Key The patient Axis I disorder , include schizoaffective disorder sleep disorder , apart schizophrenia , nicotine dependence . The patient tardive dyskinesia clinically significant movement disorder . The patient clinically significant uncontrolled medical ( include illness related cardiovascular , renal , hepatic system ) surgical condition . The patient previously receive modafinil armodafinil , patient know sensitivity ingredient study drug tablet . The patient pregnant lactate woman . ( Any woman become pregnant study withdrawn study . )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>July 2013</verification_date>
</DOC>